Clinical Trials for Urinary Bladder Cancer

Find clinical trials for urinary bladder cancer. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

NCT ID: NCT06822010

This clinical trial, called SUMMIT, is studying a new treatment approach for patients with a specific type of kidney cancer known as upper tract urothelial carcinoma. The trial is testing a combina...

Not yet recruiting

Phase: PHASE2 Type: interventional

Intravesical Gem/Doce in Patients With NMIBC

NCT ID: NCT05644041

This clinical trial is studying a treatment called intravesical Gemcitabine for patients with non-muscle invasive bladder cancer, which is a type of bladder cancer that hasn't spread deeply into th...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tucson, Arizona, United States

Quantifying Systemic Immunosuppression to Personalize Cancer Therapy

NCT ID: NCT05621837

The Serpentine trial is investigating how certain immune cells in the blood can help doctors choose the best cancer treatment for patients with specific types of advanced cancers, including melanom...

Recruiting

Type: observational Locations: Milan, , Italy

Lung US for PEEP Optimization in Robotic Radical Prostatectomy or Cystectomy Patients

NCT ID: NCT06307704

This clinical trial is studying how well a technique called lung ultrasound can help improve breathing in patients undergoing robotic surgery for prostate or bladder cancer. The goal is to find the...

Recruiting

Phase: NA Type: interventional Locations: Cairo, , Egypt

Evaluation of Non-Invasive Assays for the Detection of Urothelial Cancer

NCT ID: NCT00872495

This clinical trial is studying whether analyzing DNA and protein found in urine can help detect urothelial cancer, which affects the bladder and kidneys. The researchers want to see if this urine ...

Recruiting

Type: observational Locations: Burlington, Massachusetts, United States

Neoadjuvant Toripalimab in Combination with Gemcitabine and Cisplatin Therapy in Local Advanced Bladder Cancer Subjects

NCT ID: NCT04861584

This clinical trial is studying a new treatment approach for patients with locally advanced bladder cancer, which is cancer that has spread into surrounding tissues but not to other parts of the bo...

Recruiting

Phase: PHASE2 Type: interventional Locations: Guangzhou, Guangdong, China

Predictive Role of Microbiome in Patients With Urothelial Carcinoma

NCT ID: NCT06675656

This clinical trial is studying the role of the microbiome, which is the collection of bacteria in our bodies, in helping predict how well patients with urinary bladder cancer will respond to certa...

Not yet recruiting

Type: observational

GI-101 As a Single Agent or in Combination with Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

NCT ID: NCT04977453

This clinical trial is studying a new treatment called GI-101, which may be used alone or alongside other therapies like pembrolizumab, lenvatinib, or local radiotherapy. The main goal is to assess...

Recruiting

Phase: PHASE1 Type: interventional Locations: Huntersville, North Carolina, United States, Seoul, , Korea, Republic Of +7 more

A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study

NCT ID: NCT03844256

The CRIMI Study is a clinical trial looking at a new treatment option for adults with muscle-invasive bladder cancer, which is a type of cancer that affects the bladder and can grow into surroundin...

Recruiting

Phase: PHASE1 Type: interventional Locations: Leiden, , Netherlands, Amsterdam, Noord Holland, Netherlands +1 more

Pembrolizumab Monotherapy Following Tri-modality Treatment for Selected Patients With Muscle-invasive Bladder Cancer

NCT ID: NCT05072600

This clinical trial is studying the use of a drug called pembrolizumab as a maintenance treatment for patients with muscle-invasive bladder cancer (MIBC) who have already undergone surgery and a co...

Recruiting

Phase: PHASE2 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions